| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |